Banner, Novartis Partner on Genetics-driven Trial of Alzheimer's Treatments | GenomeWeb

NEW YORK (GenomeWeb) – The Banner Alzheimer's Institute today announced a partnership with Novartis for a trial of two investigational drugs aimed at people with a particularly high risk of developing Alzheimer's at older ages.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.